A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage

NCT06255977 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
240
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Tiantan Hospital

Collaborators